Across TCGA pan-cancer cohorts, MTND2P9 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MTND2P9’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where MTND2P9 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTND2P9 is over-expressed in tumor, although a few such as BRCA and KIRC show the opposite, repressed pattern.

KICH, BRCA, and BLCA are the cancer types where MTND2P9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND2P9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	All	+0.115	.006	4	view →
BRCA	All	IV	−0.114	.001	4	view →
BLCA	Female	IV	+0.283	.035	1	view →
KIRC	All	IV	−0.066	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MTND2P9 RNA expression & survival · all MTND2P9 data types